Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1985 3
1986 5
1987 4
1988 6
1989 7
1990 4
1991 1
1992 2
1993 1
1994 3
1996 1
1997 3
2001 1
2002 1
2004 1
2006 1
2011 2
2012 1
2014 2
2015 2
2016 2
2018 1
2019 1
2020 1
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of Cimetropium Bromide Use for the Detection of Gastric Neoplasms During Esophagogastroduodenoscopy.
Kim SY, Park JM, Cho HS, Cho YK, Choi MG. Kim SY, et al. JAMA Netw Open. 2022 Mar 1;5(3):e223827. doi: 10.1001/jamanetworkopen.2022.3827. JAMA Netw Open. 2022. PMID: 35319761 Free PMC article.
IMPORTANCE: Esophagogastroduodenoscopy (EGD) is a common procedure used to examine upper gastrointestinal diseases. Although cimetropium bromide and other antispasmodic agents are commonly administered as premedication to inhibit peristalsis during EGD examination, there a …
IMPORTANCE: Esophagogastroduodenoscopy (EGD) is a common procedure used to examine upper gastrointestinal diseases. Although cimetropium …
Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives.
Scarpignato C, Bianchi Porro G. Scarpignato C, et al. Int J Clin Pharmacol Res. 1985;5(6):467-77. Int J Clin Pharmacol Res. 1985. PMID: 3912339 Review.
The pharmacology and clinical use of cimetropium bromide is reviewed. Experimental and clinical data demonstrated that this new compound is a potent antimuscarinic and an effective antispasmodic drug. ...
The pharmacology and clinical use of cimetropium bromide is reviewed. Experimental and clinical data demonstrated that this new compo …
Cimetropium bromide does not improve polyp and adenoma detection during colonoscope withdrawal: A randomized, double-blind, placebo-controlled study.
Jung P, Park SB, Kim HW, Kang DH, W Choi C, Kim SJ, Nam HS, Ryu DG, Hong JB, Kim DJ. Jung P, et al. Medicine (Baltimore). 2018 Jun;97(25):e11253. doi: 10.1097/MD.0000000000011253. Medicine (Baltimore). 2018. PMID: 29924056 Free PMC article. Clinical Trial.
The purpose of this randomized, double-blind, placebo-controlled study was to investigate whether cimetropium bromide could improve polyp and adenoma detection in the colorectum and right colon. ...RESULTS: A total of 181 patients were analyzed; 91 patients received cim …
The purpose of this randomized, double-blind, placebo-controlled study was to investigate whether cimetropium bromide could improve p …
Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.
Centonze V, Imbimbo BP, Campanozzi F, Attolini E, Daniotti S, Albano O. Centonze V, et al. Am J Gastroenterol. 1988 Nov;83(11):1262-6. Am J Gastroenterol. 1988. PMID: 3055943 Clinical Trial.
The MHQ test showed significant improvement in the anxiety score in the cimetropium group only. The CBA test confirmed a significant decrease in anxiety state (STAI-X-1) after cimetropium treatment. Eleven patients (48%) on cimetropium reported side effects ( …
The MHQ test showed significant improvement in the anxiety score in the cimetropium group only. The CBA test confirmed a significant …
Cimetropium bromide in the treatment of crisis in infantile colic.
Savino F, Brondello C, Cresi F, Oggero R, Silvestro L. Savino F, et al. J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):417-9. doi: 10.1097/00005176-200204000-00020. J Pediatr Gastroenterol Nutr. 2002. PMID: 11930101 Clinical Trial.

Response to cimetropium bromide was 74%. Response to placebo was 33% (P < 0.05). Side effects did not differ significantly between the two groups, except sleepiness, which increased in the infants treated with cimetropium bromide. CONCLUSION: Cimetropium b

…

Response to cimetropium bromide was 74%. Response to placebo was 33% (P < 0.05). Side effects did not differ significantly between

…
Cimetropium: characterization of antimuscarinic and spasmolytic properties.
Schiavone A, Schiavi GB, De Conti L, Micheletti R, Sagrada A, Hammer R, Giachetti A. Schiavone A, et al. Arzneimittelforschung. 1985;35(5):796-9. Arzneimittelforschung. 1985. PMID: 4026901
Cimetropium displaced 3H-NMS binding from membranes derived from gastrointestinal smooth muscle. The affinity of cimetropium for intestinal muscarinic receptors was in the range 70-100 nM. ...
Cimetropium displaced 3H-NMS binding from membranes derived from gastrointestinal smooth muscle. The affinity of cimetropium f …
Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome.
Passaretti S, Guslandi M, Imbimbo BP, Daniotti S, Tittobello A. Passaretti S, et al. Aliment Pharmacol Ther. 1989 Jun;3(3):267-76. doi: 10.1111/j.1365-2036.1989.tb00213.x. Aliment Pharmacol Ther. 1989. PMID: 2520622 Clinical Trial.
Cimetropium bromide is a new antimuscarinic compound with strong antispasmodic activity. The aim of this study was to evaluate the effects of oral cimetropium bromide on total gut transit time in patients with irritable bowel syndrome. ...
Cimetropium bromide is a new antimuscarinic compound with strong antispasmodic activity. The aim of this study was to evaluate the ef …
Pain-relieving agents for infantile colic.
Biagioli E, Tarasco V, Lingua C, Moja L, Savino F. Biagioli E, et al. Cochrane Database Syst Rev. 2016 Sep 16;9(9):CD009999. doi: 10.1002/14651858.CD009999.pub2. Cochrane Database Syst Rev. 2016. PMID: 27631535 Free PMC article. Review.
In this study, more of the infants given dicyclomine responded than than those given placebo (RR 2.50, 95% CI 1.17 to 5.34). Cimetropium bromide. Data from one very low-quality study comparing cimetropium bromide with placebo showed reduced crying duration among inf …
In this study, more of the infants given dicyclomine responded than than those given placebo (RR 2.50, 95% CI 1.17 to 5.34). Cimetropium …
Cimetropium bromide as a relaxant for the radiological examination of the stomach and duodenum.
Frigerio A, Temporelli A, Imbimbo BP, Muzio F. Frigerio A, et al. Curr Med Res Opin. 1986;10(5):319-25. doi: 10.1185/03007998609111097. Curr Med Res Opin. 1986. PMID: 3816292 Clinical Trial.
A study was carried out to evaluate the efficacy of two different doses of a new hypotonizing agent, cimetropium bromide, as a premedication for X-ray of the stomach and duodenum. Forty consecutive patients were allocated at random to two groups and treated intravenously i …
A study was carried out to evaluate the efficacy of two different doses of a new hypotonizing agent, cimetropium bromide, as a premed …
Comparison between the Effectiveness of Oral Phloroglucin and Cimetropium Bromide as Premedication for Diagnostic Esophagogastroduodenoscopy: An Open-Label, Randomized, Comparative Study.
Yun HW, Shim KN, Na SK, Ryu JI, Lee MJ, Song EM, Kim SE, Jung HK, Jung SA. Yun HW, et al. Clin Endosc. 2015 Jan;48(1):48-51. doi: 10.5946/ce.2015.48.1.48. Epub 2015 Jan 31. Clin Endosc. 2015. PMID: 25674526 Free PMC article.
BACKGROUND/AIMS: Suppression of gastrointestinal (GI) peristalsis during GI endoscopy commonly requires antispasmodic agents such as hyoscine butylbromide, atropine, glucagon, and cimetropium bromide. This study examined the efficacy of oral phloroglucin for the suppressio …
BACKGROUND/AIMS: Suppression of gastrointestinal (GI) peristalsis during GI endoscopy commonly requires antispasmodic agents such as hyoscin …
60 results